Prevail Therapeutics Inc. (Nasdaq: PRVL), a biotechnology company developing potentially disease-modifying AAV-based gene therapies for patients with neurodegenerative diseases, today announced ...

Numerous studies have shown that medications in combination with psychotherapy yield the best treatment outcomes. If you have been searching for a provider with dual expertise in these critical ...

The world’s most valuable pharmaceutical company, Eli Lilly & Co., on Tuesday officially opened its new Lilly Seaport ...

Plus Therapeutics (PSTV) and SpectronRx announced the signing of a Manufacturing Services Agreement, MSA, for the production of Rhenium Obisbemeda, an innovative radiotherapy for CNS cancers ...

Therapeutics are treatments used to alleviate or prevent a particular disease. Examples of therapeutics include drug therapy, medical devices, nutrition therapy and stem-cell therapies ...

1 Day NTLA 4.60% DJIA 0.69% S&P Mid Cap 400 0.86% Health Care/Life Sciences -0.64% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent ...

Live webcasts of the presentations will be available via the Events & Presentations page in the Investors section of ADC Therapeutics' website, ir.adctherapeutics.com. A replay of each webcast ...

BTIG analyst Julian Harrison maintained a Buy rating on Protagonist Therapeutics (PTGX – Research Report) yesterday and set a price target of $51.00. Julian Harrison gave his rating based on several ...

RESEARCH TRIANGLE PARK, N.C, Oct. 22, 2024 /PRNewswire/ -- Dignify Therapeutics (Dignify), a leading developer of therapies for bladder and bowel dysfunction, has been selected as a participating ...

MONTREAL, Oct. 21, 2024 /CNW/ - Find Therapeutics Inc., a clinical-stage biopharmaceutical company focused on the development of innovative therapies for autoimmune diseases, today announced ...

Seaport Therapeutics, the startup launched earlier this year by the team behind Karuna Therapeutics, has raised another $225 million just six months after its most recent fundraising round.

RESEARCH TRIANGLE PARK, N.C., Oct. 1, 2024 /PRNewswire/ -- Dignify Therapeutics (Dignify), a specialty pharma company focused on resorting bowel and bladder function in patients with neurological ...